Newtopia is thrilled to be sharing the results of a ground breaking study on metabolic syndrome* risk reduction. The results are based on a year-long randomized control trial (RCT) with Newtopia and Aetna, the leader in medical and disability insurance, and were published in the peer-reviewed Journal of Occupational and Environmental Medicine (JOEM)
The Aetna RCT proves that employers who utilize Newtopia’s highly personalized workplace wellness and disease prevention solution reduces employee health risks and realizes significant in-year cost savings.
The RCT, which studied employees at increased risk for Metabolic Syndrome, showed yearly cost savings of $1,464 per participant in the Newtopia participant group versus a randomized control group.
This is an exciting and important milestone for corporate health and wellness programs. By achieving significant costs savings in the first year of participation, we have proven an unequivocal return on investment long before the industry standard of three to five years. More importantly, we have also shown the health benefits of clinically significant body weight reduction for Aetna’s at-risk employees, by using our innovative and personalized approach to disease prevention.